Press Releases

December 5, 2018 Lupin receives FDA approval for Decitabine for Injection, 50 mg/vial, Single-Dose Vial

November 13, 2018 Lupin receives FDA approval for Budesonide Inhalation Suspension, 0.5 mg/2 mL

November 12, 2018 Lupin launches generic Atovaquone Oral Suspension USP in the US

November 9, 2018 Lupin’s Nagpur facility receives EIR from US FDA

November 5, 2018 Lupin receives FDA approval for Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multi-dose Vials

October 22, 2018 Lupin receives FDA approval for generic Triamcinolone Acetonide Ointment USP, 0.1%

October 19, 2018 Lupin’s Pithampur Unit-3 (Indore) Inspected by US FDA

October 19, 2018 Lupin Neurosciences Announces Positive CHMP Opinion for NaMuscla™ for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

October 16, 2018 Survey Data Reveals the Need for Improved Communication Between Patients and Healthcare Providers About Bacterial Vaginosis (BV), the Most Common Gynecologic Infection in the U.S.